The new KV3.4 inhibitor BDS-I[1-8] as a potential pharmacological opportunity in Alzheimer's disease therapy
Ilaria Piccialli
Roselia Ciccone
Anna Pannaccione
1.Division of Pharmacology, Department of Neuroscience,Reproductive and Dentistry Sciences, School of Medicine, Federico Ⅱ University of Naples, Napoli, Italy2.Division of Pharmacology, Department of Neuroscience,Reproductive and Dentistry Sciences, School of Medicine, Federico Ⅱ University of Naples, Napoli, Italy3.Division of Pharmacology, Department of Neuroscience,Reproductive and Dentistry Sciences, School of Medicine, Federico Ⅱ University of Naples, Napoli, Italy
摘要：Alzheimer's disease (AD) is the most common neurodegenerative disorder and the first cause of dementia in the elderly, with no treatment able to prevent or to block disease progression. AD is characterized by memory impairment and cognitive dysfunction, followed in the late phases of the disease by severe neurodegener-ation and neuronal death.
机标关键词：
论文发表日期：2020-07-28
在线出版日期：2025-08-15（本平台首次上网日期，不代表文献的发表时间）
页数：2( 1255-1256 )